Cytomegalovirus infection;Infection a cytomegalovirus

Hematologie

Volumn 6, Issue 1, 2000, Pages 46-65

  Fillet, Anne Marie ^a   Sénéchal, Brigitte ^a   Challine Lehman, Dominique ^b   Cordonnier, Catherine ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Cytomegalovirus; Ganciclovir; pp65 antigenemia; Preemptine therapy

Indexed keywords

BENZIMIDAVIR; CIDOFOVIR; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; LOBUCAVIR;

ANEMIA; CHEMOPROPHYLAXIS; CYTOMEGALIC INCLUSION BODY DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INFECTION PREVENTION; NEPHROTOXICITY; NEUTROPENIA; PATHOPHYSIOLOGY; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; THROMBOCYTOPENIA; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 0034019765     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Sindre H, Tjoonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degre M, Hesidal K Human cytomegalovirus suppression and latency in early hematopoietic progenitor cells. Blood 1996 , 88 : 4526-33.
2. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, John G Fibroblasts, epithelial cells, endothelial cells, and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues J Gen Virol 1995 , 76 741-50.
3. Hemmings DG, Kilani R, Nykiforuk C, Preiksaitis J, Guilbert LJ. Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol 1998 ; 72 : 4970-9
4. Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA. Human cytomegalovirus persistently infects aortic endothelial cells J Virol 1998 ; 72 : 5661-8.
5. Waldman WJ, Knight DA, Huang EH, Sedmak DD Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis 1995 ; 171 263-72
6. Grundy J, Lawson KM, MacCoimac LP, Flatchar JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit Virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 1998 ; 177 1465-74
7. Söderberg-Naucler C, Fish KN, Nelson JA Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997 ; 91 . 119-26
8. Reusser P, Fisher LD, Buckner CD, Thomas ED, Meyers JD. Cytomegalovirus infection after autologous bon marrow transplantation : occurrence of cytomegalovirus disease and effect on engraftment Blood 1990 ; 75 1888-94.
9. Bolger GB, Sullivan K, Storb M, Witherspoon RP, Weiden PL, Stewail P, Sanders J, Meyers JD, Martin PF, Doney KC, Deeg HJ, Clift RA, Buckner CD, Appelbaum FR, Thomas ED Second marrow infusion for poor graft function after allogeneic bone marrow trans plantation Bone Marrow Transplant 1986 , 1 21-30
10. Mutter W, Reddehase MJ, Busch FW, Buhring H, Koszinowski UH Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host J Exp Med 1988 , 167 1645-58
11. Simmons P, Kaushansky K, Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression perturbation of stromal cell function versus direct infection of myeloid cells Proc Natl Acad Sci USA 1990 , 87 . 1386-90
12. Steffens HP, Podlech J, Kurz S, Angele P, Dreis D, Reddehase MJ Cytomegalovirus inhibits engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipients stroma J Virol 1998 , 72 : 5006-15
13. + progenitor cells by human cytomegalovirus evidence for inhibition of hematopoiesis and viral replication Blood 1996 , 88 1277-83
14. Zhuravskaya T, Maciejewski JP, Netski DM, Bruening E, Maackintosh FR, St Jeor S Spread of human cytomegalovirus (CMV) after infection of human hematopoietic progenitor cells model of CMV latency Blood 1997 , 90 2482-91
15. Dobonici M, Podlech J, Steffens HP, Maiberger S, Reddehase MJ. Evidence against a key role for transforming growth factor-beta1 in cytomegalovirus-induced bone marrow aplasia J Gen Virol 1998 ; 798 : 867-76
16. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L. Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy withdrawal of chemokines from the environment of cytomegalovirus-infected cells J Exp Med 1998 ; 188 855-66
17. Riddell SR, Waranabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD Restoration of viral immunity in immunodeficient humans by adoplive transfer of T-cell clones Science 1992, 257 238-41
18. Gilbert MJ, Riddell SR, Plachter B, Greenberg PD Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product Nature 1996 ; 383 : 720-2.
19. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to cytosol Cell 1996 , 84 769-79
20. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH. Restoration of cytomegalovirus antigen presentation by gamma Interferon combats viral escape. J Virol 1994 , 68 289-97.
21. Knight DA, Waldman WJ, Sedmak DD Human cytomegalovirus does not induce HLA class II expression on arterial endothelial cells Transplantation 1997 , 63 1366
22. Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier LL Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection : the role of endogenous class I major histocompatibility complex and a viral class I homolog J Exp Med 1998 ; 187 1681-7
23. Britt WJ, Alford CA. Cytomegaloviius In . Fields BN, Knipe DM, Howley PM, et al , eds. Fields virology Third edition Philadelphia Lippincott-Raven Publishers, 1996 . 2493-523
24. Gratacap-cavallier B, Morand P, Dutertre N, Bosson JL, Baccard-Longere M, Jouk PS, Cons C, Jean D, Cart-Lamy P, Vandakerckhore C, Berbassa A, Micoud M, Seigneurin JM Cytomegalovirus infection in pregnant women Seroepidemiological prospective study in 1,018 women in Isère J Gynecol Obstet Biol Reprod (Paris) 1998 , 27 161-6
25. Atkinson K, Nivison-Smith I, Dodds A, Concannon A, Milliken S, Downs K. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989 Bone Marrow Transplant 1998 , 21 . 691-5.
26. Nguyen Q, Champlin R, Giralt S, Rolston K, Raad I, Jacobson K, Ippoliti C, Hecht D, Tarrand J, Luna M, Whimbey E. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipient Clin Infect Dis 1999, 28 : 618-23.
27. Robain M, Carré N, Salmon-Ceron D, Dussaix E, Meyer L et le groupe SEROCO Prévalence et incidence de l'infection par le cytomégalovirus chez les sujets infectés par le VIH-1 Presse Med 1998 ; 27 949-53.
28. Costagliola D, for the Clinical epidemiology group from CISIH Trends in incidence of clinical manifestations of HIV infection and antiretroviral prescriptions in French university hospitals 5th Conference on refroviruses and opportunistic infections Chicago, 1998, Abstract 1182.
29. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nature Medicine 1998 ; 4 : 953-6
30. Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child to mother transmission of CMV by changing behaviors : a randomized controlled trial. Ped Infect Dis 1996 ; 15 240-6.
31. Persoons MC, Stals FS, Van Dam Mieras MC, Bruggeman MC Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J Pathol 1998 ; 184 . 103-9
32. Eddleston M, Peacok S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients J Infect Dis 1997 , 24 52-61
33. Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, Sause P, Perrin G, Gouin F Cytomegalovirus, an unexpected cause of ventilator associated pneumonia. Anesthesiology 1996, 84 : 880-7
34. Boeckh MJ, Ljungman P. Cytomegalovirus infection after BMT In : Bowden RA, Ljungman P, Paya CV, eds Transplant Infections. Philadelphia Lippincott-Raven Publishers, 1998 215-27.
35. Falagas ME, Snydman DR, Griffith J, Werner BG, Freeman R, Rohrer R, the Boston center for liver transplantation CMVIG study group Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients Clin Infect Dis 1997 , 25 : 314-7.
36. De Otero J, Gavalda J, Muno E, Vargas V, Calico I, Llopart L, Rosselo J, Margarit C, Pahissa A Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation Clin Infect Dis 1998 , 26 856-70
37. Bouedjoro-Camus MC, Novella JL, Toupance O, Wynckel A, Carquin J, Jolly D, ChanardJ La maladie à cytomégalovirus, facteur de risque de rejet aigu d'allogreffe rénale. Presse Med 1999 ; 28 619-24.
38. Streblow DN, Soderberg-Naucler C, Vieira J, et al The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration Cell 1999, 99 : 511-20
39. Matthes-Martin S, Aberle SW, Peters C, Holter W, Popow-Kraupp T, Potschger U, Fritsch G, Ladenstein R, Rosenmayer A, Dieckmann K, Gadner H CMV-viremia during allogenic bone marrow transplantation in paediatric patients association with survival and graft-versus-host disease Bone Marrow Transplant 1998 , 21 S53-6.
40. Verbraak FD, Bruinenberg M, van dan Horn GJ, Meenken C, van den Lelij A, Hoyng CB, Kijlstra A, Peek R Cytomegalovirus (CMV) strain differences between the eye and blood in AIDS patients with CMV retinitis AIDS 1998, 12 713-8
41. Anduze-Farris B, Fillet AM, Boukli N, Gasnault J, Lancar R, Katlama C and the NeuroCMV study group Foscarnet-ganciclovir combination for central nervous system (CNS) infection with cytomegalovirus (CMV) in HIV patients an open pilot study (ANRS 037) AIDS (sous presse)
42. Herry I, Cadranel J, Antoine M, Meharzi J, Michelson S, Parrot A, Rozenbaum W, Mayaud C. Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS : a new clinical entity ? Clin Infect Dis 1990 , 22 . 616-20
43. Salomon N, Gomez T, Perlman DC, Laya L, Eber C, Mildvan D Clinical features and outcome of HIV-related cytomegalovirus pneumonia. AIDS 1997 , 11 : 319-24
44. Lazzarotto T, Varani S, Spezzacatena P, Pradelli P, Potena L, Lombardi A, Ghiseith V, Gabrielli L, Abate DA, Magelli C, Landini MP Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients. J Infect Dis 1998 , 178 : 1145-9.
45. Velzing J, Rothbarth PH, Kroes ACM, Quint WGV Detection of cytomegalovirus mRNA and DNA, encoding the immediate early gene in peripheral blood leucocytes from immunocompromised patients J Med Virol 1994 ; 42 164-9
46. Fest T, Deschaseaux M, Mougin C, Cahn JY, Dupond JL, Herve P In situ hybridization for the detection of cytomegalovirus in blood or bone marrow leucocytes after allogeneic bone marrow transplantation. Br J Haematol 1994 ; 386 : 619-23.
47. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, Dussaix E Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary cytomegalovirus infection in pregnant woman J Infect Dis 1997, 175 944-6
48. Alpert G, Mazeron MC, Colimon R, Plotkin S Rapid detection of human cytomegalovirus in the urine of humans. J Infect Dis 1985 , 152 631-3
49. Schafer P, Tenschert W, Cremaschi L, Cutensohn K, Laufs R Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allogralt recipients by PCR. J Clin Microbiol 1998 , 36 : 1008-14
50. Boeckh M, Boivin G. Quantification of cytomegalovirus : methodology aspects and clinical applications Clin Microbiol Rev 1998 ; 11 533-54.
51. Revello MG, Zavaltoni M, Sarasini A, Percivolle E, Simoncini L, Gerna G Human cytomegalovirus in blood of immunocompetent persons during primary infection pronostic implantations for pregnancy J Infect Dis 1998 , 177 : 1170-5
52. Cohen JI, Corey GR Cytomegolovirus infection in normal host Medicine (Baltimore) 1985, 64 . 100-14
53. Lesprit P, Scieux C, Lemann M, Carbonelle E, Modai J, Molina JM Use of cytomegalovirus (CMV) antigenemia assay for the rapid diagnosis of primary cytomegalovirus infection in hospitalized adults Clin Infect Dis 1998 ; 26 : 646-50
54. Studahl M, Beraptrom T, Ekeland-Sjöberg K, Ricksten A Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patient as a sign of active infection. J Med Virol 1995 ; 46 274-80
55. Fillet AM Les pneumonies à cytomégalovirus Annales de l'Institut Pasteur/Actualités 1995, 1 9-17.
56. Zaia JA Infections in organ transplant recipients In Richman DG, Whitley RJ, Hayden FG Clinical virology New York, Churchill Livingstone, 1997 : 87-111
57. Hebart H, Gamer D, Loeffler J, Mueller C, Sinzger C, John G, Bader P, Klingebiel T, Kanz L, Einsele H Evaluation of Murex CMV DNA hybrid capture assay for detection and quantification of cytomegalovirus infection in patients following allogeneic stem cell transplantation, J Clin Microbiol 1998 , 36 1333-7.
58. Gor D, Sabin C, Prentice HG, Vyas N, Man S, Griffiths PD, Emery VC. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients : relation-ship between peak virus load, donors recipients serostatus, acute GVHD and CMV disease Bone Marrow Transplant 1998 ; 21 : 597-605.
59. Gozlan J, Laporte JP, Lesage S, Labopin M, Najman A, Gorin NC, Petit JC Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J Clin Microbiol 1996 , 34 2085-8.
60. Reina J, Fernandez-Baca V, Saurina J, Blanco I, Munar M. Shell-viral culture and pp65 antigenemia assay in the detection of cytomegalovirus in the first blood sample of renal transplant recipients. J Med Virol 1998 ; 55 : 240-2.
61. Gaeta A, Nazzari C, Angeletti S, Lazzarini M, Mazzn E, Mancini C. Monitoring for cytomegalovirus infection in organ transplant recipients analysis of pp 65 antigen, DNA and late mRNA in peripheral blood leukocytes J Med Virol 1997 , 53 . 189-95
62. Gerna G, Zavattoni M, Baldanti F, Sarasini A, Chezzi L, Grossi P, Revello MG Human cytomegalovirus (CMV) leukaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart lung transplant recipients with primary CMV infection. Transplantation 1998 ; 65 . 1378-85
63. Manez R, Kusne S, Rinaldo C, Aguado JM, St George K, Grossi P, Frye B, Fung JJ, Ehrlich GD Time to detection of cytomegalovirus (CMV) DNA in blood leucocytes is a predictor for the development of CMV disease in cytomegalovirus-seronegative recipients of allografts from cytomegalovirus-seropositive donors following liver transplantation J Infect Dis 1996, 173 : 1072-6
64. Gerna G, Zavattoni M, Percivalle E, Grossi P, Torsellini M, Revello MG Rising levels of human cytomegalovirus (CMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary cytomegalovirus infection J Clin Microbiol 1998 ; 36 : 1113-6
65. Mendez JC, Espy MJ, Smith TF, Wilson JA, Wiesner R, Paya CV Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation 1998 , 65 : 1477-81.
66. Roberts TC, Brennan DC, Buller RS, Gaudreault-Keener, Schnitzler MA, Sternhell KE, Garlock KA, Singer GG, Storch GA Quantitative polymerase chain reaction to predict occurence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients J Infect Dis 1998 , 178 626-35
67. Imbert-Marcille BM, Cantarovich D, Ferre-Ambineau V, Richel B, Sonlillou JP, Billaudel S. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients Transplantation 1997 ; 63 : 1476-81.
68. Barrett-Muir WY, Aitken C, Templeton K, Raftery M, Kelsey SM, Breuer J Evaluation of the Murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell viral assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients. J Clin Microbiol 1998 , 36 . 2554-6
69. Lam KM, Oldenburg N, Khan MA, Gaylore V, Mikhail GW, Strouhal PD, Middeldorp JM, Banner N, Yacoub M Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients J Heart Lung Transplantation 1998 , 17: 555-65
70. Block MJ, Goossens VJ, Vanherle SJV, Top B, Tacken N, Middeldorp JM, Christiaans MHL, van Hooff JP, Bruggeman CA Diagnosis value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification J Clin Microbiol 1998 , 36 . 1341-6.
71. Salmon D, Lacassin F, Harzic M, Leport C, Perronne C, Bricaire F, Brun-Vezinet F, Vildé JL Predictive value of cytomegalovirus viremia for the occurrence of cytomegalovirus organ involvement in AIDS J Med Virol 1990 , 32 160-3
72. Boivin G, Mandfield J, Toma E, Murray G, Lalonde R, Tevere VJ, Sun R, Bergeron MG Evaluation of AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus infected subjects J Clin Microbiol 1998 , 36 2509-13.
73. Freymuth F, Gennetay E, Petit-Jean J, Eugene G, Hurault de Ligny B, Ryckelynck JP, Legoff C, Hazera P, Bazin C Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus detection J Clin Microbiol 1994 , 166 1223-7
74. Spector SA, Wong R, Hsia K, Pilcher M, Stempien MJ Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients J Clin Invest 1998 , 101 497-502.
75. Fillet AM, Costagliola D, Sénéchal B, Houhou N, Gozlan J, Boukli N, Matheron S, Dény P, Katlama C, Freymuth F, Salmon D, Mazeron MC, Predivir ANRS study group. Predicitive value of peripheral blood leukocytes (PBL) cytomegalovirus (CMV) quantification by PCR assay on occurrence of CMV disease as compared to others CMV blood markers in HIV infected patients under HAART included in the Predivir cohort Seventh international cytomegalovirus workshop, Brighton, UK, 28 april-1 may 1999
76. Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, van Loon AM, Klapper PF For the European Union concerted action on virus meningitidis and encephalitis J Neurovirology 1998 ; 4 : 120-32.
77. Révello MG, Baldanti F, Furione M, Sarasini A, Percivalle E, Zavattoni M, Gerna G Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection J Med Virol 1995 , 47 462-6
78. Crumpacker CS. Ganciclovir. N Engl J Med 1996 ; 335 : 721-30
79. Hammer SM, Inouye RT Antiviral agents in Richman DG, Whitley RJ, Hayden FG, eds Clinical Virology New York Churchill Livingstone 1997 185-250
80. Gone E, Saliba F, Valdecasas Garcia JC, O'Grady J, Pescovitz MD, Lyman S, Robinson CA Randomized trials of efficacy and safeiy of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients Lancet 1997 , 350 1729-33
81. Brennan DC, Garlock KA, Singer GG, Schnitzler MA, Lippmann BJ, Buller RS, Gaudreault-Keener M, Lowell JA, Shenoy S, Howard TK, Storch GA Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients Transplantation 1997 , 62 1843-6.
82. Ljungman P, Cordonnier C, Einsele H, Bender-Gotze C, Bosi A, Dekker A, de la Camara R, Gmur J, Newland AC, Prentice HG, Robinson AJ, Rovira M, Rosier W, Veil D Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients : a report from the European group for blood and marrow transplantation (EBMT) Infectious diseases working party of the EBMT. Bone Marrow Transplant 1998 , 21 : 473-6
83. Mazeron MC. Resistance du cytomégalovirus aux antiviraux Virologie 1997 , 1 95-102.
84. Erice A, Borrell N, Li W, Miller WJ, Balfour HH. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis J Infect Dis 1998; 178 531-4.
85. Wolf DG, Yaniv I, Honigman A, Kassis I, Schonfeld T, Ashkenazi S Early emergence of ganciclovir resistant human cytomegalovirus strains in children with primary combined immunodeficiency J Infect Dis 1998 ; 178 : 535-8
86. Kruger RM, Shannon WD, Arens MQ, Lynch JP, Storch GA, Trulock EP. The impact of ganciclovir-resistant cytomegalovirus infection after lung-transplantation Transplant 1999, 68 1272-9
87. Baldanti F, Underwood MR, Stanat SC, Biron KK, Chou S, Sarasini A, Silini E, Gerna G Single amino acid changes in the DNA polymerase confers foscarnet resistance and slow growth phenotype while mutations in the UL97-encoded phosphotransferase confers ganciclovir resistance in three double resistant cytomegalovirus strains recovered from patients with AIDS. J Virol 1996, 70 1390-5
88. Salmon D, Fillet AM, Aboulker JP, Gérard L, Houhou N, Carrière I, Ostinelli J, Vildé JL, Brun-Vézinet F, Leport C and ANRS CYTOVIR group Effect of a 14-day course of foscarnet on CMV blood markers in a randomized study of HIV-infected patients with persistent CMV viremia. Clin Infect Dis 1999 , 28 901-28.
89. Jouan M, Saves M, Tubiana R, Cassoux N, Carcelain G, Fillet AM, Olivier C, Ncin M, Chene G, Katlama C RESTIMOP (ANRS 078) a prospective multicentre study to evaluate the discontinuation of maintenance therapy for CMV retinitis in HIV-patients receiving HAART Sixth conference on retroviruses and opportunistic infections Chicago, 31 janvier-4 février 1999